Publication | Open Access

Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study

RheumatologyModerate-to-severe Ulcerative ColitisGastroenterologyPediatricsPediatric GastroenterologyPaediatric RheumatologyUlcerative ColitisPaediatric PatientsMedicinePhase 3